BlackRock Group’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-370,913
Closed -$46.3M 2963
2013
Q3
$46.3M Sell
370,913
-81,367
-18% -$10.3M 0.03% 561
2013
Q2
$39.3M Buy
+452,280
New +$41.6M 0.03% 560

BlackRock Group's ONXX Position: Q4 2013 in Review

BlackRock Group sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q4 2013, closing a stake of 370,913 shares — an estimated $46.3M sold.

BlackRock Group first reported a position in ONXX in Q2 2013 and held it in 2 quarters. The position peaked at $46.3M in Q3 2013. 0 funds tracked by Wall St. Rank hold ONXX as of Q4 2013.

  • BlackRock Group reported no remaining ONYX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • BlackRock Group sold 370,913 ONYX PHARMACEUTICALS INC shares in Q4 2013, an estimated $46.3M.
  • BlackRock Group first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • BlackRock Group's ONYX PHARMACEUTICALS INC position peaked at $46.3M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q4 2013.

Based on BlackRock Group's 13F filing for Q4 2013, filed 12 Feb 2014.